Fisher Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,864
| Closed | -$406K | – | 1085 |
|
|
2024
Q4 | $406K | Sell |
32,864
-368,217
| -92% | -$4.22M | ﹤0.01% | 804 |
|
|
2024
Q3 | $4.56M | Buy |
401,081
+155,419
| +63% | +$1.56M | ﹤0.01% | 496 |
|
|
2024
Q2 | $1.75M | Buy |
245,662
+13,985
| +6% | +$107K | ﹤0.01% | 604 |
|
|
2024
Q1 | $1.55M | Buy |
231,677
+3,617
| +2% | +$24.9K | ﹤0.01% | 633 |
|
|
2023
Q4 | $1.48M | Hold |
228,060
| – | – | ﹤0.01% | 638 |
|
|
2023
Q3 | $2.15M | Sell |
228,060
-41,662
| -15% | -$501K | ﹤0.01% | 620 |
|
|
2023
Q2 | $3.77M | Sell |
269,722
-26,752
| -9% | -$456K | ﹤0.01% | 581 |
|
|
2023
Q1 | $5.56M | Buy |
296,474
+28,547
| +11% | +$469K | ﹤0.01% | 529 |
|
|
2022
Q4 | $3.69M | Buy |
267,927
+5,769
| +2% | +$88.4K | ﹤0.01% | 564 |
|
|
2022
Q3 | $5.01M | Buy |
262,158
+40,465
| +18% | +$737K | ﹤0.01% | 466 |
|
|
2022
Q2 | $3.38M | Buy |
221,693
+13,551
| +7% | +$200K | ﹤0.01% | 463 |
|
|
2022
Q1 | $4.24M | Buy |
208,142
+40,489
| +24% | +$824K | ﹤0.01% | 464 |
|
|
2021
Q4 | $4.89M | Buy |
167,653
+41,808
| +33% | +$1.2M | ﹤0.01% | 467 |
|
|
2021
Q3 | $2.71M | Buy |
125,845
+11,222
| +10% | +$271K | ﹤0.01% | 494 |
|
|
2021
Q2 | $2.94M | Sell |
114,623
-1,054
| -0.9% | -$22.5K | ﹤0.01% | 482 |
|
|
2021
Q1 | $2.11M | Buy |
115,677
+55,790
| +93% | +$927K | ﹤0.01% | 526 |
|
|
2020
Q4 | $691K | Buy |
59,887
+770
| +1% | +$7.04K | ﹤0.01% | 652 |
|
|
2020
Q3 | $450K | Buy |
+59,117
| New | +$448K | ﹤0.01% | 677 |
|
Other funds holding CDMO
Fisher Asset Management's CDMO Position: Q1 2025 in Review
Fisher Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 32,864 shares — an estimated $406K sold.
Fisher Asset Management first reported a position in CDMO in Q3 2020 and held it in 18 quarters. The position peaked at $5.56M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Fisher Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Fisher Asset Management sold 32,864 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $406K.
- Fisher Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
- Fisher Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $5.56M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Fisher Asset Management's 13F filing for Q1 2025, filed 14 May 2025.